Will genome sequencing be routine in cancer care and research?

By Dr Philippa Brice – PHG Foundation  

PHG Foundation

A pilot trial reported in Science Translational Medicine further underlines the potential benefit of genomic tumour sequencing to inform clinical management.
Samples from a small number of patients with different forms of advanced cancer were examined using whole genome,exome and RNA transcriptomesequencing, in each case revealing abnormalities that suggested specific treatments.
(